Analysis of prognosis-related risk factors in patients with acute ischemic stroke

GUO Siping; YANG Lihui; DONG Wanli

doi:10.7619/jcmp.20201527

Journal of Clinical Medicine in Practice > 2021 > 25(7): 39-41, 46. > DOI: 10.7619/jcmp.20201527

GUO Siping, YANG Lihui, DONG Wanli. Analysis of prognosis-related risk factors in patients with acute ischemic stroke[J]. Journal of Clinical Medicine in Practice, 2021, 25(7): 39-41, 46. DOI: 10.7619/jcmp.20201527

Citation:

PDF (446 KB)

Analysis of prognosis-related risk factors in patients with acute ischemic stroke

1.
Department of Neurology, Dushu Lake Hospital of Suzhou City in Jiangsu Province, Suzhou, Jiangsu, 215000
2.
Department of Neurology, The First Hospital Affiliated to Suzhou University, Suzhou, Jiangsu, 215000

More Information

Received Date: November 23, 2020
Available Online: April 20, 2021
Published Date: March 31, 2021

Graphical Abstract

Abstract

Abstract

Objective To analyze the risk factors of prognosis in patients with acute ischemic stroke.
Methods A total of 240 hospitalized patients with acute ischemic stroke were selected. Demographic and clinical materials such as age, gender, past medical history, laboratory examination results and 3-month modified Rankin Scale (mRS) score were collected and analyzed.
Results Multivariate Logistic regression analysis showed that score of National Institutes of Health Stroke Scale (NIHSS) (OR=1.036, 95% CI, 1.016 to 1.056, P < 0.001), fasting blood glucose (OR=1.196, 95% CI, 1.066 to 1.341, P=0.002) and C reactive protein (OR=1.176, 95% CI, 1.116 to 1.240, P < 0.001) were independent influencing factors for poor prognosis in patients with acute ischemic stroke.
Conclusion The NIHSS score on admission, fasting blood glucose and C reactive protein levels are of great significance for 3-month prognosis evaluation in patients with acute ischemic stroke.
- acute ischemic stroke,
- prognosis,
- C reactive protein,
- hyperglycemia after stroke,
- modified Rankin scale

FullText(HTML)

References (25)

References

[1]	GIRARD M P, KATZ J, PERVIKOV Y, et al. Report of the 6th meeting on the evaluation of pandemic influenza vaccines in clinical trials World Health Organization, Geneva, Switzerland, 17-18 February 2010[J]. Vaccine, 2010, 28(42):6811-6820. doi: 10.1016/j.vaccine.2010.07.034
[2]	BENJAMIN E J, MUNTNER P, ALONSO A, et al. Heart Disease and Stroke Statistics-2019 Update:A Report From the American Heart Association[J]. Circulation, 2019, 139(10):e56-e528. http://med.wanfangdata.com.cn/Paper/Detail/PeriodicalPaper_PM22179539
[3]	中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2014[J].中华神经科杂志, 2015, 48(4):246-257. doi: 10.3760/cma.j.issn.1006-7876.2015.04.002
[4]	中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组.中国各类主要脑血管病诊断要点2019[J].中华神经科杂志, 2019, 52(9):710-715.
[5]	VERRO P, TANENBAUM L N, BORDEN N, et al. Clinical application of CT angiography in acute ischemic stroke[J]. Clin Neurol Neurosurg, 2007, 109(2):138-145. doi: 10.1016/j.clineuro.2006.07.002
[6]	RIDKER P M, SILVERTOWN J D. Inflammation, C-reactive protein, and atherothrombosis[J]. J Periodontol, 2008, 79(8 Suppl):1544-1551. http://eurheartj.oxfordjournals.org/lookup/external-ref?access_num=18673009&link_type=MED&atom=%2Fehj%2F34%2F5%2F354.atom
[7]	ZHOU Y, HAN W, GONG D, et al. Hs-CRP in stroke:A meta-analysis[J]. Clin Chim Acta, 2016, 453:21-27. doi: 10.1016/j.cca.2015.11.027
[8]	ROSENFELD M E. Inflammation and atherosclerosis:direct versus indirect mechanisms[J]. Curr Opin Pharmacol, 2013, 13(2):154-160. doi: 10.1016/j.coph.2013.01.003
[9]	KOENIG W. High-sensitivity C-reactive protein and atherosclerotic disease:from improved risk prediction to risk-guided therapy[J]. Int J Cardiol, 2013, 168(6):5126-5134. doi: 10.1016/j.ijcard.2013.07.113
[10]	ROSENFELD M E. Inflammation and atherosclerosis:direct versus indirect mechanisms[J]. Curr Opin Pharmacol, 2013, 13(2):154-160. doi: 10.1016/j.coph.2013.01.003
[11]	SEO W K, SEOK H Y, KIM J H, et al. C-reactive protein is a predictor of early neurologic deterioration in acute ischemic stroke[J]. J Stroke Cerebrovasc Dis, 2012, 21(3):181-186. doi: 10.1016/j.jstrokecerebrovasdis.2010.06.002
[12]	HUŢANU A, IANCU M, BÂLAŞA R, et al. Predicting functional outcome of ischemic stroke patients in Romania based on plasma CRP, sTNFR-1, D-Dimers, NGAL and NSE measured using a biochip array[J]. Acta Pharmacol Sin, 2018, 39(7):1228-1236. doi: 10.1038/aps.2018.26
[13]	郭四平, 倪健强, 孙晓欣, 等.急性脑梗死并发全身炎性反应综合征的危险因素分析及对患者预后的影响[J].中华老年心脑血管病杂志, 2016, 18(2):168-170. doi: 10.3969/j.issn.1009-0126.2016.02.016
[14]	BARTH E, ALBUSZIES G, BAUMGART K, et al. Glucose metabolism and catecholamines[J]. Crit Care Med, 2007, 35(Suppl 9):S508-S518. http://www.ncbi.nlm.nih.gov/pubmed/17713401
[15]	KRUYT N D, BIESSELS G J, DEVRIES J H, et al. Hyperglycemia in acute ischemic stroke:pathophysiology and clinical management[J]. Nat Rev Neurol, 2010, 6(3):145-155. doi: 10.1038/nrneurol.2009.231
[16]	YONG M, KASTE M. Dynamic of hyperglycemia as a predictor of stroke outcome in the ECASS-Ⅱ trial[J]. Stroke, 2008, 39(10):2749-2755. doi: 10.1161/STROKEAHA.108.514307
[17]	CAPES SE, HUNT D, MALMBERG K, et al. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients:a systematic overview[J]. Stroke, 2001, 32(10):2426-2432. doi: 10.1161/hs1001.096194
[18]	TZIOMALOS K, DIMITRIOU P, BOUZIANA S D, et al. Stress hyperglycemia and acute ischemic stroke in-hospital outcome[J]. Metabolism, 2017, 67:99-105. doi: 10.1016/j.metabol.2016.11.011
[19]	ROQUER J, GIRALT-STEINHAUER E, CERDA G, et al. Glycated Hemoglobin Value Combined with Initial Glucose Levels for Evaluating Mortality Risk in Patients with Ischemic Stroke[J]. Cerebrovasc Dis, 2015, 40:244-250. doi: 10.1159/000440735
[20]	BARRETO A D, FORD G A, SHEN L, et al. Randomized, Multicenter Trial of ARTSS-2(Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke)[J]. Stroke, 2017, 48(6):1608-1616. doi: 10.1161/STROKEAHA.117.016720
[21]	HE J, ZHANG Y, XU T, et al. Effects of immediate blood pressure reduction on death and major disability in patients with acute ischemic stroke:the CATIS randomized clinical trial[J]. JAMA, 2014, 311(5):479-489. doi: 10.1001/jama.2013.282543
[22]	ZHANG R, ZHONG C, ZHANG Y, et al. Immediate Antihypertensive Treatment for Patients With Acute Ischemic Stroke With or Without History of Hypertension:A Secondary Analysis of the CATIS Randomized Clinical Trial[J]. JAMA Netw Open, 2019, 2(7):e198103. doi: 10.1001/jamanetworkopen.2019.8103
[23]	TZIOMALOS K, GIAMPATZIS V, BOUZIANA S D, et al. Prognostic significance of major lipids in patients with acute ischemic stroke[J]. Metab Brain Dis, 2017, 32(2):395-400. doi: 10.1007/s11011-016-9924-9
[24]	LIU L, YIN P, LU C, et al. Association of LDL-C/HDL-C Ratio With Stroke Outcomes Within 1 Year After Onset:A Hospital-Based Follow-Up Study[J]. Front Neurol, 2020, 11:408-417. doi: 10.3389/fneur.2020.00408
[25]	WANG Y, WEI C, SONG Q, et al. Reduction in the Ratio of Low-density Lipoprotein Cholesterol to High-density Lipoprotein Cholesterol is Associated with Increased Risks of Hemorrhagic Transformation in Patients with Acute Ischemic Stroke[J]. Curr Neurovasc Res, 2019, 16(3):266-272. doi: 10.2174/1567202616666190619151914

Cited By

Get Citation

PDF

XML

Article views (389) PDF downloads (35)

Turn off MathJax

Article Contents

Abstract

References

Analysis of prognosis-related risk factors in patients with acute ischemic stroke

Abstract

References

Catalog

Export File

Citation

Format

Content